Intech Investment Management LLC Regulus Therapeutics Inc. Transaction History

Intech Investment Management LLC

  • $10.8 Billion
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 20, 2025
BUY
$0.97 - $1.75 $3,812 - $6,877
3,930 Added 13.8%
32,410 $56,000
Q4 2024

Feb 10, 2025
BUY
$1.4 - $1.71 $39,872 - $48,700
28,480 New
28,480 $44,000

Others Institutions Holding RGLS

# of Institutions
4
Shares Held
4.52M
Call Options Held
0
Put Options Held
0
View Full List

About Regulus Therapeutics Inc.

RGLS Quotes by TradingView
  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $119M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email